VS
stockvs
Go to ScreenerHub
0QQ6.L

0QQ6.L vs LLY

LLY

In the past 12 months, LLY returned +20% while 0QQ6.L gained 1%.

0QQ6.L
0QQ6.L

Roche Holding AG

$418.64
-10.9%(1M)
Market Cap356.9B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio45.65
ROE41.2%
P/B Ratio9.11
Dividend Yield3.0%
LLY
LLY

Eli Lilly and Company

$988.79
-4.6%(1M)
Market Cap934.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio43.57
ROE97.9%
P/B Ratio33.89
Dividend Yield0.6%
Performance Comparison

Historical returns across multiple timeframes

LLY leads 6/8
0QQ6.L

0QQ6.L

Roche Holding AG

+1.3%

1Y Return

LLY

LLY

Eli Lilly and Company

+19.9%

1Y Return

0QQ6.L
0QQ6.L
LLY
LLY

Short Term

1M-6M

LLY
+6.2%

Medium Term

YTD-1Y

LLY
+5.7%

Long Term

3Y-10Y

LLY
+627.4%

Valuation

Compare price multiples and valuation ratios

0QQ6.L: 4LLY: 1
Metric0QQ6.LLLYWinner
P/E Ratio

Price to earnings ratio

45.6543.57LLY
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.5714.490QQ6.L
P/B Ratio

Price to book ratio

9.1133.890QQ6.L
P/FCF Ratio

Price to free cash flow ratio

20.59105.290QQ6.L
EV/EBITDA

Enterprise value to EBITDA

12.7434.980QQ6.L
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

0QQ6.L: 0LLY: 6
Metric0QQ6.LLLYWinner
Gross Margin

Gross profit margin

73.5%83.8%LLY
Operating Margin

Operating profit margin

28.4%45.6%LLY
Net Margin

Net profit margin

12.3%31.7%LLY
ROE

Return on equity

41.2%97.9%LLY
ROA

Return on assets

12.8%18.3%LLY
ROIC

Return on invested capital

18.8%30.2%LLY

Growth

Compare revenue and earnings growth rates

0QQ6.L: 0LLY: 6
Metric0QQ6.LLLYWinner
Revenue Growth (YoY)

Year-over-year revenue growth

-1.4%44.7%LLY
Revenue Growth (3Y)

3-year revenue CAGR

-0.9%31.7%LLY
Revenue Growth (5Y)

5-year revenue CAGR

1.1%21.6%LLY
EPS Growth (YoY)

Year-over-year EPS growth

55.9%96.0%LLY
EPS Growth (3Y)

3-year EPS CAGR

1.1%51.7%LLY
EPS Growth (5Y)

5-year EPS CAGR

-0.6%28.8%LLY

Balance Sheet & Risk

Compare financial stability and debt levels

0QQ6.L: 2LLY: 3
Metric0QQ6.LLLYWinner
Debt/Equity

Debt to equity ratio

1.211.600QQ6.L
Current Ratio

Current assets to current liabilities

1.291.58LLY
Quick Ratio

Quick assets to current liabilities

1.021.19LLY
Interest Coverage

EBIT to interest expense

10.7337.34LLY
Beta

Stock volatility vs market

0.210.430QQ6.L
Summary
LLY wins 3-1

Valuation

0QQ6.L

Profitability

LLY

Growth

LLY

Balance Sheet

LLY

0QQ6.L is more attractively valued. LLY shows stronger profitability. LLY demonstrates better growth. LLY has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into 0QQ6.L and LLY with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/0QQ6.L/vs/LLY" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare 0QQ6.L vs LLY on stockvs.app
</a>